# Implementation of infrared and Raman modalities for glycosaminoglycan characterization in complex systems

Hossam Taha Mohamed, Valérie Untereiner, Ganesh Sockalingum, Stephane Brezillon

► To cite this version:

Hossam Taha Mohamed, Valérie Untereiner, Ganesh Sockalingum, Stephane Brezillon. Implementation of infrared and Raman modalities for glycosaminoglycan characterization in complex systems. Glycoconjugate Journal, 2017, 34 (3), pp.309-323. 10.1007/s10719-016-9743-6. hal-02929941

HAL Id: hal-02929941

https://hal.univ-reims.fr/hal-02929941

Submitted on 14 Jan 2022

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_1.png" /></figure>

Distributed under a Creative Commons Attribution 4.0 International License
<figure><img src="image_2.png" /></figure>

# Implementation of infrared and Raman modalities for glycosaminoglycan characterization in complex systems

Hossam Taha Mohamed<sup>1,2,3</sup> · Valérie Untereiner<sup>2,3,4</sup> · Ganesh D. Sockalingum<sup>2,3</sup> · Stéphane Brézillon<sup>2,5 ID</sup>

Received: 30 June 2016 / Revised: 27 September 2016 / Accepted: 12 October 2016 / Published online: 7 December 2016
© The Author(s) 2016. This article is published with open access at Springerlink.com

**Abstract** Glycosaminoglycans (GAGs) are natural, linear and negatively charged heteropolysaccharides which are incident in every mammalian tissue. They consist of repeating disaccharide units, which are composed of either sulfated or non-sulfated monosaccharides. Depending on tissue types, GAGs exhibit structural heterogeneity such as the position and degree of sulfation or within their disaccharide units composition being heparin, heparan sulfate, chondroitine sulfate, dermatan sulfate, keratan sulfate, and hyaluronic acid. They are covalently linked to a core protein (proteoglycans) or as free chains (hyaluronan). GAGs affect cell properties and functions either by direct interaction with cell receptors or by sequestration of growth factors. These evidences of divert biological roles of GAGs make their characterization at cell and tissue levels of importance. Thus, non-invasive techniques are interesting to investigate, to qualitatively and quantitatively characterize GAGs *in vitro* in order to use them as diagnostic biomarkers and/or as therapeutic targets in several human diseases including cancer. Infrared and Raman microspectroscopies and imaging are sensitive enough to

differentiate and classify GAG types and subtypes in spite of their close molecular structures. Spectroscopic markers characteristic of reference GAG molecules were identified. Beyond these investigations of the standard GAG spectral signature, infrared and Raman spectral signatures of GAG were searched in complex biological systems like cells. The aim of the present review is to describe the implementation of these complementary vibrational spectroscopy techniques, and to discuss their potentials, advantages and disadvantages for GAG analysis. In addition, this review presents new data as we show for the first time GAG infrared and Raman spectral signatures from conditioned media and live cells, respectively.

**Keywords** Glycosaminoglycans · Infrared spectroscopy · Raman spectroscopy · CHO-WT · CHO-745 · Chondrocytes · Conditioned media · Data analysis

**Abbreviations**

<table><tr><td>CE</td><td>Capillary electrophoresis</td></tr><tr><td>CM</td><td>Conditioned medium</td></tr><tr><td>CS</td><td>Chondroitin sulfate</td></tr><tr><td>DS</td><td>Dermatan sulfate</td></tr><tr><td>ESI</td><td>Electrospray-ionization</td></tr><tr><td>ECM</td><td>Extracellular matrix</td></tr><tr><td>EGF</td><td>Epidermal growth factor</td></tr><tr><td>FACE</td><td>Fluorophore assisted carbohydrate electrophoresis</td></tr><tr><td>LC-MS</td><td>Liquid chromatography-mass spectrometry</td></tr><tr><td>FGF</td><td>Fibroblast growth factor</td></tr><tr><td>FTIR</td><td>Fourier transform infrared</td></tr><tr><td>GAG</td><td>Glycosaminoglycan</td></tr><tr><td>GPC</td><td>Gel permeation chromatography</td></tr><tr><td>HA</td><td>Hyaluronic acid</td></tr><tr><td>HCA</td><td>Hierarchical cluster analysis</td></tr></table>

<figure><img src="image_3.png" /></figure>

<figure><img src="image_4.png" /></figure>

<footnote>Stéphane Brézillon
stephane.brezillon@univ-reims.fr</footnote>

<footnote n="1">¹ Department of Zoology, Faculty of Science, Cairo University, Giza, Egypt</footnote>

<footnote n="2">² CNRS UMR7369, Matrice Extracellulaire et Dynamique Cellulaire (MEDyC), Reims, France</footnote>

<footnote n="3">³ MéDIAN-Biophotonique et Technologies pour la Santé, UFR de Pharmacie, Reims, France</footnote>

<footnote n="4">⁴ Plateforme d'imagerie Cellulaire et Tissulaire (PICT), Université de Reims Champagne-Ardenne, Reims, France</footnote>

<footnote n="5">⁵ Laboratoire de Biochimie Médicale et Biologie Moléculaire, UFR de Médecine, Université de Reims Champagne-Ardenne, Reims, France</footnote>
<table><tr><td>HEP</td><td>Heparin</td></tr><tr><td>HS</td><td>Heparan sulfate</td></tr><tr><td>HPLC</td><td>High-performance-liquid chromatography</td></tr><tr><td>IR</td><td>Infrared</td></tr><tr><td>KS</td><td>Keratan sulfate</td></tr><tr><td>LIF</td><td>Laser induced fluorescence</td></tr><tr><td>MALDI</td><td>Matrix-assisted laser desorption/ionization</td></tr><tr><td>MS</td><td>Mass spectrometry</td></tr><tr><td>MWCO</td><td>Molecular weight cut off</td></tr><tr><td>NMR</td><td>Nuclear magnetic resonance</td></tr><tr><td>PCA</td><td>Principal component analysis</td></tr><tr><td>PFA</td><td>Paraformaldehyde</td></tr><tr><td>PG</td><td>Proteoglycan</td></tr><tr><td>RMS</td><td>Raman microspectroscopy</td></tr><tr><td>RPIP</td><td>Reverse-phase ion-pair</td></tr><tr><td>SLRP</td><td>Small leucine rich proteoglycan</td></tr><tr><td>TGF</td><td>Tumor growth factor</td></tr><tr><td>UPLC</td><td>Ultra-performance liquid chromatography</td></tr><tr><td>VEGF</td><td>Vascular endothelial growth factor</td></tr><tr><td>VS</td><td>Vibrational spectroscopy</td></tr></table>

# Introduction

## Pathophysiological aspects of glycosaminoglycans

Glycosaminoglycans (GAGs) and proteoglycans (PGs) are major constituents of the extracellular matrix (ECM). PGs are present at the cell surface, in the ECM, in intracellular granules and in basement membranes [1]. GAGs are unbranched and negatively charged heteropolysaccharides composed of repeating disaccharide units of alternating uronic acids and N-acetylated hexosamine [2]. Most of GAGs are covalently attached to core proteins to form PGs [3, 4]. Numbers of attached GAG side chains vary from only one chain as decorin, a Small Leucine Rich Proteoglycan (SLRP), to more than 100 chains as aggrecan [3]. According to the types of monosaccharide in the repeating unit and their sulfation, there are different major categories of GAGs: hyaluronan (HA), dermatan sulfate (DS) and chondroitin sulfate (CS), heparin (HEP), heparan sulfate (HS) and keratan sulfate (KS) [3, 5]. KS is the only GAG that loses uronic acid and contains galactose in its disaccharide units [3]. HA is a non-sulfated GAG devoid of a covalently bound core protein. HA is synthesized at the extracellular surface of the plasma membrane and plays an important role in tissue homeostasis and cancer progression [6]. All sulfated GAGs are synthesized at the Golgi apparatus and modified by O-sulfotransferases [7]. The ionic properties due to the presence of carboxylate and sulfate groups make GAG molecules able to attract water [3]. GAGs diversity is due to the modifications in sulfation positions and epimerization of the glucuronic acids to iduronic acids [3]. The structure and abundance of GAG chains vary

according to the tissue. For example, lumican displays four potential sites for the substitution by N-linked KS or oligosaccharides situated at positions 87, 126, 159 and 251 of the human core protein. In the cornea, lumican is a KSPG characterized by a smear on immunoblots, with a molecular mass ranging approximately from 70 to 300 kDa. In contrast, in skin, lumican is present in the dermis in the form of a glycoprotein (57 kDa) [8]. Proteoglycans enrolled several biological functions. They modulate cell growth-factor activation, regulate collagen fibrillogenesis, affect tumor cell growth and invasion, and influence corneal transparency. As a KSPG, lumican regulates corneal transparency [9] and stimulates keratocytes migration [10]. In contrast, as a glycoprotein, it inhibits melanoma cell migration [8]. The first known biological function of GAGs is the clinical anticoagulant role of HEP. Numerous genetic studies on GAG biosynthetic enzymes revealed direct evidences of involvement of GAGs in cell growth including transforming growth factor (TGF), and fibroblast growth factor (FGF) signalling pathways [11].

Mutations in the genes encoding sulfotransferases and glycosyltransferases enzymes caused a number of genetic disorders. Sulfotransferases are responsible for the synthesis of sulfated GAGs side chains of proteoglycans. Recently, studies revealed that mutations in genes encoding CS and DS biosynthetic enzymes cause several disorders of connective tissues [12]. In some corneal diseases, sulfated GAGs were considered to be pathogenic factors [13]. GAGs and proteoglycans play important roles in cancer progression, where changes in their expression and enzymes involved in their biosynthesis and/or degradation contribute to the cancer progression [2]. In breast cancer, overexpression of hyaluronan synthase 2 increases ErbB2-dependent signalling leading to disease progression [14], while suppression of hyaluronan synthase 2 leads to inhibition of tumorigenesis and progression of breast cancer [15]. In addition, CSPGs were shown to activate the extracellular signal-regulated kinase and focal adhesion kinase in melanoma [16]. Decorin was demonstrated to regulate epidermal growth factor receptor signalling, thus controlling proliferation in melanoma [6]. Any changes in the expression of GAGs reduce cell adhesion and increase cancer cell invasion [2]. Syndecans, acting in harmony with integrins and hyaluronan signalling through CD44 was shown to increase cancer cell motility [17]. GAGs play a major role in metastasis and angiogenesis. HA expression affects the metastatic potential of mouse mammary carcinoma cells [18]. Degradation of cell-surface HS chains and matrix HSPGs by heparanase increase invasion and metastasis [19]. Syndecan-1 regulates the adhesion of cancer cells to lymphatic vessel endothelium [20]. Inhibition of perlecan expression decreases the growth of colon carcinoma cells and tumor angiogenesis [21]. CS has an antiangiogenic effect by inhibiting the migration of transendothelial monocytes [6]. Moreover, decorin was shown to be angiostatic due to a high-affinity binding to the
VEGFR-2 [22]. Decorin is an antagonistic ligand for VEGFR-2 and a 12 amino acid peptide within the leucine-rich-repeat 5 domain of decorin protein was responsible for the most avid VEGFR-2 binding, antagonizing VEGF actions [22]. In stem cells, GAGs and PGs are considered as specific markers of progenitor cells [23]. In addition, they play major supportive roles in developmental signalling and provide a sanctuary for preservation of cell “stemness” as demonstrated for CSPG in neural stem cells [24] and HSPG and CSPG in hematopoietic precursor cells [25]. These evidences of divert biological roles of GAGs make their characterization at cell and tissue levels of importance. Thus, non-invasive techniques are interesting to investigate, to qualitatively and quantitatively characterize GAGs *in vitro* in order to use them as diagnostic biomarkers and/or as therapeutic targets in several human diseases including cancer.

## Bioanalytical methods for glycosaminoglycan characterization

GAGs display an important heterogeneity in their molecular structure including within their uronic acid, hexosamine, and the position of the sulfate groups. Detection and identification of GAGs structure are crucial to understand their biological role. Extraction of GAGs is mainly performed by enzymatic depolymerisation with exogenous proteinase or sodium hydroxide [26]. Physicochemical analysis of GAGs involved ion pairing chromatography and Mass Spectrometry (MS) applied after preincubation of the samples with specific enzymes. The chemical analysis of such preparations is a tedious task involving enzymatic depolymerisation of GAG chains with specific bacterial enzymes followed by disaccharide analysis with Gel Permeation Chromatography (GPC) [27], High-Performance-Liquid Chromatography (HPLC), Ultra-Performance Liquid Chromatography (UPLC) [28], Nuclear Magnetic Resonance (NMR) spectroscopy, Mass Spectrometry (MS) [29], Capillary Electrophoresis (CE) [30] and Fluorophore Assisted Carbohydrate Electrophoresis (FACE) [31, 32].

Liquid chromatography-mass spectrometry (LC-MS) and MS, have become widely used in analysis of GAGs without interference by impurities in biological samples [33, 34]. Reverse-phase ion-pair (RPIP)-HPLC depends on volatile lipophilic ion-pairing reagents in the mobile phase to favour analyte attachment on a hydrophobic C18 stationary phase and evaporation in electrospraying, leading to make these ion-pairing reagents compatible with electrospray ionization (ESI)-MS [35, 36]. RPIP-HPLC-MS is applicable for several analytes, ranging from unsulfated to highly sulfated GAGs [28, 37]. RPIP-UPLC-MS provides even higher resolution, sensitivity, efficiency and peak capacity, at high pressures (up to 108 Pa) with columns packed with 1.7 µm particles [38]. There are several factors affecting RPIP-HPLC-MS or

RPIP-UPLC-MS separation of GAGs, such as the concentration of ion pairing reagent, counter-ion and pH. Moreover, the routine structural analysis of GAGs in a cell, tissue or biological fluid sample requires multiple selective polysaccharide lyase treatments, multiple disaccharide isolation steps, multiple HPLC or UPLC columns with different mobile phases and different ESI-MS detection methods [37].

MS is another powerful technique for structural analysis of GAGs. Soft ionization techniques, including ESI and matrix-assisted laser desorption/ionization (MALDI) are more dedicated to the analysis of neutral oligosaccharides and their attached peptide and lipid conjugates [29, 39]. MALDI time-of-flight (TOF) MS [40, 41] and ESI-MS [42] are useful approaches for the structural analysis of GAG-derived oligosaccharides. Both ESI-MS and MALDI-TOF-MS are convenient for structural analysis of large polar macromolecules. NMR spectroscopy allows determining the saccharide composition, ring conformation, glycosidic linkage, and sulfation modality of GAGs [43, 44]. Regrettably, this technique is very limited due to the requirement of relatively large amounts (milligrams) of pure GAG sample.

CE is one of the most sensitive techniques for GAGs analysis due to its resolving power, separation efficiency, short time analysis and straightforward operation [45]. Moreover, CE has higher compatibility with several detection methods, such as ultraviolet (UV) spectroscopy, MS [46], NMR spectroscopy and Laser Induced Fluorescence Detection (LIF) [47, 48]. Currently, determination of GAG disaccharides using CE-LIF requires separate retrievals from multiple lyase-digestion steps, and separated analysis of HS/HP and CS/DS in two chromatographic runs, leading to a complicated and more time-consuming technique. However, the results from different analyses showed inaccuracy to the calculated ratio of HS/HP and CS/DS GAGs obtained from one sample. Chang and collaborators used a simplified procedure to do GAG-derived disaccharides analysis from biological source using a single CE-LIF experiment [49].

FACE is a reliable and rapid technique to analyse unsaturated disaccharides on the base of electrophoresis after derivatization with a fluorophore, such as AMAC. FACE presents the advantages of the fluorescence of AMAC for high sensitivities and the possibility to analyze large number of samples with one electrophoretic apparatus at the same time [50]. FACE is able to determine disaccharides from a very small quantity of sample (0.05 ng). Karousou and his colleagues demonstrated that FACE is an accurate and highly selective for CS in biological samples and established FACE technique can be easily used for the contemporaneous separation of CS/DS and hyaluronan [51]. Thus, FACE analysis is a powerful tool to characterize low quantities of different sulfated CS disaccharides.

To better understand, the roles of GAGs in physiology and pathophysiology, it is important to be able to determine the
structure of GAGs from a small quantity of tissue, but even better at the cell scale according to the cell phenotype. Spectroscopic markers characteristic of reference GAG molecules have been identified previously based on their molecular structures by Raman and infrared (IR) microspectroscopies [52, 53]. These techniques are sensitive enough to discriminate different cell types according to their capacity to synthetise GAGs [54]. Both IR and Raman microspectroscopies are highly sensitive to the structure, composition, and environment of the molecules constituting the studied specimen. Moreover, these biophotonic methods are rapid, non-destructive and do not require external markers. In terms of structural and compositional analysis, IR and Raman spectroscopies are able to give a complete “molecular fingerprint” for GAGs in the studied sample.

## Principles of vibrational spectroscopy

Infrared (IR) and Raman spectroscopies are vibrational spectroscopic techniques based on light-matter interactions. They allow to probe the chemical content of all forms of matter via transitions in their vibrational energy states. The information obtained in the form of a spectral signature characteristic of the state, molecular structure and composition, and environment of the sample. These techniques are currently used to characterize simple molecules, complex biological macromolecules (lipids, proteins, nucleic acids, polysaccharides), and even highly complex systems like cells and tissues [55]. In infrared spectroscopy, the sample interacts with an incident light from a polychromatic source comprising a set of wavelengths that span over the mid-infrared range (2.5–25 µm). The mid-infrared source carries the energy that exactly corresponds to the energy differences between the ground state vibrational energy levels of the molecule. As a consequence, a molecule excited by a mid-infrared source may absorb this energy and in this case a specific bond will start vibrating. This is the case when a molecular vibration is infrared-active, i.e., it undergoes a change in its dipole moment during this interaction. Infrared spectroscopy analyses the intensity difference between the incident light and light transmitted or reflected by the sample. The infrared spectrum therefore displays the absorption intensity at each frequency. This spectrum can be interpreted qualitatively via the position of the bands, which is directly related to the frequency of vibration and therefore to the chemical information, and quantitatively *via* its intensity, which can be associated to its concentration. IR spectroscopy measures the absolute frequencies of vibration.

Raman spectroscopy is a scattering process that is based on the interaction of the sample with a monochromatic source, generally a laser. During this interaction, the molecule gains energy and reaches a “polarized” or “virtual” state, which is not energetically stable and consequently the molecule comes down to the initial energy level by emission of photons. For a

large majority of cases, the molecule will come back to its initial energy level, i.e., the lowest vibrational energy level of the ground state. This gives rise to elastically scattered photons with the same frequency as that of the incident laser. This event is the most probable and therefore predominates and is termed as “Rayleigh scattering.” Since one gets back the same frequency as the incident excitation, Rayleigh light does not carry any chemical information. A second possibility is that the scattered light is inelastic in nature, i.e., the transition to the ground state gives rise to scattered photons that have either gained energy (anti-Stokes Raman) or given away some energy (Stokes Raman). In both cases, the difference between the initial and final states gives the energy of the vibrating bond and also corresponds to the difference in energy levels measured in IR spectroscopy (see Fig. 1). However, it must be noted that, while in IR spectroscopy a measurement of the absolute frequency is made, in Raman spectroscopy the measured frequency is relative since a difference is calculated with respect to the excitation frequency. This frequency difference is also called “Raman shift.” The spectral information

<figure><img src="image_5.png" /></figure>

**Fig. 1** Energy diagram showing transitions involved during infrared absorption and Raman scattering processes. Rayleigh (ordinary) scattering is when the photon is absorbed to a higher virtual state and is instantly scattered (emitted) elastically back to the initial state, without any change in its frequency. The photons emitted by Raman Stokes scattering usually have a lower frequency (red shifted) than that of the photons absorbed and these photons are inelastically scattered, transferring some of their energy to the molecule. The reverse is also possible; the photons emitted have a higher frequency than the photons absorbed (blue shifted). This is called Raman Anti-Stokes, but it is less likely at room temperature as the majority of electrons are in the ground state. Both Raman Stokes and anti-Stokes give the vibrational information as the Raman shift, which is the difference between the two vibrational energy states. The difference between the ground state and the final state gives the vibrational energy ($v_{vib}$) of the system and corresponds to energy states measured in IR spectroscopy. The vibrational energy $v_{vib}$ is related to a specific molecular vibration and to the structure and the chemical composition of the molecules of the samples. Double and dashed arrows represent Raman shift and overtone respectively
obtained with the anti-Stokes and Stokes scattering is identi-
cal, but since in the former the initial state of the molecules is
not the lowest energy level, the anti-Stokes is less intense
because the number of events involved is less. Therefore, in
spontaneous Raman measurements, spectrometers are gener-
ally designed to capture mainly the Raman Stokes signal,
while the Rayleigh and anti-Stokes scattering are rejected.
The Raman spectrum therefore displays the Stokes scattering
intensity with respect to the Raman shift. In the same way as
with IR, the position of the bands is related to the chemical
nature of the sample. Its intensity can be used in a semi-
quantitative manner.

On the other hand, a molecular vibration is said to be
Raman-active if it undergoes a change in its polarizabil-
ity during the interaction. Although the origins of the
physical phenomena are not the same (absorption for IR
and scattering for Raman), both techniques inform on
the chemical nature of the sample. They are also com-
plementary because certain vibrational modes that are
active in IR may not be active in Raman and *vice-versa*.
So, combining both techniques can give the full vibra-
tional signature. These signatures consist of several vi-
brational modes of molecular linkages in a molecular
group: symmetrical or antisymmetrical stretching, scis-
soring, rocking, wagging, and twisting. Depending on
the applications, lasers for Raman spectroscopy can
range from the UV to the near-infrared. UV and visible
lasers produce photons of higher frequency and can
therefore cause sample heating. Also, the “polarized”
state can coincide with the first excited electronic level
giving rise to fluorescence emission, which will mask
the Raman signal. Sample degradation and fluorescence
can be circumvented by increasing the excitation wave-
length to the near-infrared (less energetic photons).

State-of-the-art of application of vibrational
spectroscopy to the study of glycosaminoglycans

The first IR spectra of GAGs were published more than
50 years ago [56]. Later studies analysed the differences of
the spectra in solid-state and in aqueous solutions [57], or
with different hydration rates [58–63] or from different
species (CS from different sources of cartilage, such as
crocodile, shark, chicken, ray) [64]. Several bands were
identified by spectral comparison [65] especially those as-
sociated with sulfate vibrations [66–70] and different con-
formations of iduronate [71–74]. Prepared GAGs [70] or
GAGs present in natural, PG forms [75] were character-
ized. The evolution of molecular changes with aging was
also studied [76, 77]. More recently, the association of
chemometrics with sensitive spectroscopic microtech-
niques showed a good classification of some types of
GAGs [75–78]. These studies concerned only a particular

type of GAGs or digested molecules. The first IR spectral
signatures of GAG in complex biological systems like
cells were also recently demonstrated [54]. However, IR
microspectroscopy is limited in terms of spatial resolution
and also requires sample drying. In order to study live
cells, Raman microspectroscopy (RMS) is potentially in-
teresting to perform studies in physiological conditions.
Raman spectra of GAGs were published 38 years ago
[66]. It is highly sensitive to the structure, composition,
and environment of the molecules constituting the studied
specimen [79].

The association of spectroscopy with powerful data analyt-
ical methods gives more insight into the interpretation of the
spectral information and molecular-level phenomena. When
coupled with a microscope, vibrational microspectrocopies
become highly sensitive methods capable of probing at the
micron level, thus necessitating only small amounts of sample.
Raman and Raman optical activity of GAGs was described
[80]. RMS was used to study spectral signatures of various
mixtures of GAGs with collagens [81]. Raman spectral imag-
ing of single living cancer cells was previously described
[82–85]. Moreover, vibrational microspectroscopy was shown
to be both qualitative and semi-quantitative. Surface-enhanced
Raman scattering (SERS) was used to map glycan expression
for the identification of cancerous cells [86]. Raman SERS was
reported to be highly sensitive to detect HEP [87].

The aim of the present review is to describe the
implementation of these complementary vibrational
spectroscopies (VS) techniques and to discuss their po-
tentials, advantages and disadvantages for GAG analy-
sis. In addition, this review presents new data as we
show for the first time GAG infrared and Raman spec-
tral signatures from conditioned media and live cells
(CHO-745, CHO-WT and chondrocytes), respectively.

Vibrational spectroscopy: sample preparation
for Raman and infrared analysis

CHO-WT cell line and its mutant counterpart, CHO-745, lack-
ing xylosyltransferase associated with low GAG synthesis and
primary culture from human chondrocytes expressing high
levels of GAGs were used in the study.

Extraction of total GAGs and quantification of sulfated GAGs

The workflow for the extraction and quantification of sul-
fated GAGs is given in Fig. 2a. Cells underwent starvation
in growth media without serum for 24 h at 37 °C with 5 %
CO₂. Then, conditioned media (CM) were collected and
were centrifuged to discard the cell debris. The collected
CM was concentrated using Vivaspin™ column
<figure><img src="image_6.png" /></figure>

<figure><img src="image_7.png" /><figcaption>**Fig. 2** Workflow from conditioned media to biochemical analysis and Raman spectral analysis (a) and from cell suspension to Raman spectral analysis of fixed and live cells (b)</figcaption></figure>

(10,000 Da MWCO) (GE Healthcare Bio-Sciences AB, Sweden). CM was incubated overnight with proteinase at 37 °C for a non-specific protein digestion. Proteinase digestion was stopped by addition of NaCl (50nM) and incubation at 100 °C for 1 min. After cooling down, the samples were centrifuged to pellet the digested proteins. GAGs were precipitated from the supernatant by addition of ethanol saturated sodium acetate and incubation at 4 °C for 3 h. Purified GAGs were centrifuged and air-dried. Dried GAG pellets were resuspended in sterile distilled water. A Blyscan™ assay (Biocolor, Westbury, NY, USA) was performed to determine the concentration of sulfated GAGs. The absorbance was measured at 656 nm from 3 replicates for each sample.

## Sample preparation for Raman microspectroscopy

The workflow for micro-Raman analysis of extracted GAGs (Fig. 2a) involves the following steps. Three drops of 2 µL of resuspended extracted GAGs were deposited on CaF₂ substrate and air-dried. The measurements were performed with a Raman microspectrometer (Horiba JobinYvon, Villeneuve d'Ascq, France) equipped with an Olympus microscope (model: BX40) and a dry objective (X100, NA = 0.9). The source was a 660 nm diode laser (Fig. 2b). The schematic for the micro-Raman analysis of single fixed and live cells is illustrated in Fig. 2b. At 80 %

of confluence, cells were detached and cell pellets were collected after centrifugation. Cells were resuspended in complete cell culture medium, seeded on CaF₂ substrate (10⁴ cells/mL) and incubated for 2 days at 37 °C with 5 % CO₂. For fixed cells analysis, cells were fixed with 4 % paraformaldehyde (PFA) and air-dried. For live cells, the substrate was washed then immersed in 0.9 % NaCl solution. The Raman analysis was done by using a water-immersion objective lens.

## Sample preparation for infrared analysis

The workflow for cell and extracted GAGs preparation for FTIR analysis is given in Fig. 3. Five µL of cell suspension (10⁵ cells/µL) or 5 µL of re-suspended GAGs extract (1 µg/µL) were analysed with a high-throughput screening HTS-XT extension coupled to a Tensor 27 FTIR spectrometer (Bruker Optics GmbH, Etlingen, Germany). The samples were deposited in triplicate onto a high-throughput 384-well silicon plate and air-dried (Fig. 3a). Single cells and extracted GAGs (Fig. 3b) were analysed with an FTIR microimaging system Spotlight 400 (Perkin Elmer, Courtaboeuf, France). Cells (1.5 × 10⁴ cells/mL) were seeded on a CaF₂ substrate for 48 h at 37 °C. Then, they were fixed with 4 % PFA and air-dried. For extracted GAGs, three drops of 2 µL were deposited on a CaF₂ window and air-dried.

## Vibrational spectroscopy and data acquisition

### Infrared spectroscopy data acquisition

The IR acquisitions of the samples were performed in transmission mode, in the spectral range 4000–400 cm⁻¹, at a spectral resolution of 4 cm⁻¹, with 64 scans and 128 scans for extracted GAGs and cells, respectively. Before each sample measurement, the silicon plate background was recorded and automatically removed from the sample signal. One spectrum was obtained from each well. Acquisitions were performed with the OPUS software (Version 6.0, Bruker Optics, Germany). For FTIR imaging, the analysis was acquired in transmission mode at a spatial resolution of 6.25 µm/pixel for cells and at 25 µm/pixel for GAG extracts. The spectral range 4000–800 cm⁻¹ was used at a spectral resolution of 4 cm⁻¹. For fixed cells and extracted GAGs, 128 scans and 16 scans were used, respectively. Spectral images of fixed cells were taken from the whole single cell and spectral images of GAG samples were taken across the diameter of each dried drop. The substrate background is automatically subtracted from the signal. The images of single cells or GAG drops were averaged and the obtained spectra were pre-processed.
<figure><img src="image_8.png" /><figcaption>**Fig. 3** Workflow from the cell suspension or extracted GAGs to high-throughput FTIR spectral analysis (a) and from single cells or extracted GAGs to FTIR microimaging system (b)</figcaption></figure>

## Raman microspectroscopy data acquisition

All Raman measurements were carried out with a 660 nm laser excitation. The spectral resolution was 4 cm⁻¹ giving by a grating of 950 lines/mm. For extracted GAGs, an acquisition of 30 spectra per dried drop was performed in the point mode over the 600–1750 cm⁻¹ spectral range with an accumulation time of 60s. For fixed and live cells, the acquisitions were performed in the point mode (spatial resolution of ~1 µm) from cell cytoplasms over the 600–1750 cm⁻¹ spectral range and an acquisition time of 45 seconds/point. For extracted GAGs and fixed cells, a X100 dry objective (NA = 0.9) was used while a X100 immersion objective (NA = 0.9) was employed for live cells measurements.

## Spectral data pre-processing and analysis

For FTIR and Raman analysis, the pre-processing was specific for each technique. Figure 4 shows the workflow for pre-processing of a typical FTIR spectrum. An example is shown for a single fixed CHO-WT cell. This was carried out with the OPUS software (Version 6.0, Bruker Optics, Germany). Raw spectra, initially recorded between 4000 and 750 cm⁻¹ were reduced to the 4000–800 cm⁻¹ spectral window to remove the noisy end of the spectrum. Spectra were then baseline corrected (elastic function, 9 points), their second derivative computed to increase spectral differences, and vector normalised.

Figure 5 shows the workflow for pre-processing of a typical Raman spectrum. An example is shown for a single live

CHO-WT cell. This was carried out with a home-made software using the Matlab environment (The MathWorks, Inc., Natick, USA). Raw spectra were recorded between 600 and 1750 cm⁻¹. Before each Raman experiment, the following spectra were recorded to correct for instrument and substrate contributions: dark current (measurement without laser and objective) and optics (with laser and objective) to estimate the noise, white light (halogen lamp) for intensity calibration, neon lamp for frequency calibration, and finally the CaF₂ window to remove substrate contribution. Each raw Raman spectrum undergoes these steps before smoothing with a Savistsky-Golay function (polynom order 3 and window 9) to reduce noise, baseline and substrate subtraction, and vector normalisation on the whole spectral range.

After this first step, data from these two techniques were processed with exploratory techniques like hierarchical cluster analysis (HCA) and principal component analysis (PCA). These clustering methods based on distance calculation and variance analysis, respectively, allowed to view, in an unsupervised way, how spectra group together. HCA computes the Euclidian distance between the spectra using the Ward's algorithm. This classification allows the combination of spectra with a minimum Euclidian distance in the same cluster. The distance between each group gives an estimate of the spectral difference between spectral clusters. The result of clustering is represented in a tree called dendrogram. PCA is a statistical analysis based on the orthogonal transformation to convert a group of observations of possible correlated variables into a group of linearly uncorrelated principal components (PCs). PCA is
FTIR spectral pre-processing steps

<figure><img src="image_9.png" /><figcaption>**Fig. 4** Steps for pre-processing of an FTIR spectrum. Example is given for a single fixed CHO-WT cell</figcaption></figure>

an exploratory method and can be performed by singular
value decomposition of a data matrix after mean centering.

Results of a PCA are presented as a plot of PC scores or
PC loadings.
<figure><img src="image_10.png" /><figcaption>**Fig. 5** Steps for pre-processing of a Raman spectrum. Example is given for a single live CHO-WT cell</figcaption></figure>
Infrared and Raman microspectroscopies:
rapid and non-invasive screening techniques
distinguishing cell types exhibiting low to high levels
of GAG synthesis

In terms of structural and compositional analysis, VS is
able to give a complete “molecular fingerprint” of the
studied sample, depending on their molecular structure.
We previously showed that VS such as IR and Raman
microspectroscopies are promising techniques to charac-
terize, differentiate, and classify GAGs types and sub-
types despite their close molecular structures [52]. Some
characteristic spectral regions and bands were identified
and used in combination with chemometric methods such
as HCA and PCA, to characterize standard GAGs by VS
[52, 53]. These approaches could be extremely useful for
performing quality tests on GAG samples. Moreover, VS
was shown to be both qualitative and quantitative.

Brézillon and collaborators [54] applied IR
microspectroscopy and imaging to identify in a first step
the spectroscopic signatures of GAG standards, GAG-
Collagen mixtures, and in a second step cells expressing
different levels of GAGs, both in suspensions and in
isolated single cells. Cartilage chondrocytes are the cells
with the highest capacity for GAGs synthesis. The

CHO-745 cell line, lacking xylosyl transferase, is the
only known mutant deficient in the synthesis of CS
and HS which results in a decreased amount of GAGs
in these cells, compared to the wild type CHO (CHO-
WT). We first reported on IR spectroscopy of major
types of GAGs, i.e., HA, HEP, HS, C4S, C6S, DS
and GAG-collagen mixtures. We next investigated
cellular IR spectroscopy of CHO-745, CHO-WT,
chondrocytes [54] and SK-MEL-28, dermal fibroblast
(unpublished data) in suspension and performed IR im-
aging of single cells. Spectral data were analysed by
HCA chemometric method in order to characterize these
different cell types exhibiting from low to high levels of
GAG synthesis. We identified the infrared spectral sig-
natures of standard GAGs and differentiated cell types
based on their capacity of GAG synthesis [54].

In addition to the previous study performed on fixed cells [54], we show in the present review in Fig. 6, CHO-745, CHO-WT, and chondrocytes CM characterized by their ability of synthesizing GAGs from very low to high levels. Normalized FTIR spectra of these cell types were obtained from GAGs extracted from CM (Fig. 6a and b) and single cell analyses (Fig. 6c and d), respectively. Visually, the spectral profiles (not shown) of chondrocytes, CHO-WT and CHO-745 were similar in

<figure><img src="image_11.png" /><figcaption>**Fig. 6** Hierarchical cluster and principal component analyses from FTIR spectra of CM extracted GAGs and single cells. HCA (a) and PCA (b) analyses from FTIR spectra of CM extracted GAGs (n = 6) obtained from CHO-745, CHO-WT and chondrocytes. HCA (c) and PCA (d) analyses from FTIR spectra of fixed CHO-745, CHO-WT and chondrocytes (n = 10). *Red and black triangles* correspond to two different individuals. HCA and PCA analyses were calculated on the second derivative of the mean spectra of each cell type in the spectral range 1350–900 cm⁻¹. All replicate spectra of the same sample are well clustered together</figcaption></figure>
the 1800–900 cm⁻¹ spectral range, with, however, some minor modifications for chondrocytes in the 1350–900 cm⁻¹ spectral range (GAGs absorption region). The extracted GAGs from CM and the fixed cells FTIR spectra were analysed by the HCA analysis (Fig. 6a and c). This method was performed on all second derivative spectra for each single cells and for CM in the 1350–900 cm⁻¹ spectral range. The spectra of cells and CM were grouped in the same cluster and exhibited a low degree of heterogeneity, indicating a good reproducibility of the measurements and, therefore, a low intra-group variability (Fig. 6a and c). The inter-group variability was sufficiently high to distinguish the three cell types (Fig. 6a and c). The dendrogram also revealed the inter-group variability enabling to differentiate between chondrocytes and both CHO-WT and CHO-745 at both single cells and CM levels. The clear-cut classification using the second derivative spectra in the 1350–900 cm⁻¹ spectral range indicated that chondrocytes differed from CHO-WT and CHO-745 by their spectral differences in the GAGs absorption region. Moreover, these FTIR spectra were analysed by PCA (Fig. 6b and d). PCA analysis for single cells and CM showed low intra-group variability in both CHO cell types while higher variability was observed in chondrocytes. This result might be explained at least in part by inter-individual differences from one patient to another one and the degree of cell differentiation. In addition, the inter-group variability was sufficiently high to distinguish the three cell types. The PCA score plot of the three cell types showed that the first two PCs exhibited the highest explained variance. For CM, the PC1 carried 87 % of the total variance and allowed clear separation of CHO-745 and CHO-WT from chondrocytes. These results also demonstrated that PC2, representing 12 % of the total variance, discriminated efficiently CHO-745 and CHO-WT. For single cells, PC1 representing 89 % of the total variance, allowed clear separation of CHO-745 and CHO-WT from chondrocytes. The PC2 representing 9 % of the total variance could separate CHO-745 and CHO-WT. Therefore, the capacity of GAG synthesis of different cell types can be clearly delineated using HCA and PCA analyses. Therefore, this methodology was demonstrated to be a useful approach for screening and identifying cells that exhibit the capacity for GAG synthesis. Furthermore, the method is rapid, non-destructive, non-contact, and label-free. Taking into account the importance of GAGs in the biomedical field, it will be challenging, to transpose this methodology to tissue analysis in order to identify GAG molecules in normal tissues and during pathophysiological conditions.

Since IR microspectroscopy is limited in spatial resolution and requires sample drying, RMS is potentially interesting to perform studies in physiological conditions.

The application of Raman spectroscopy and microscopy within biology is rapidly increasing because it can provide chemical and compositional information. Moreover, it does not suffer from water interference. In addition, it does not require extensive sample preparation. Biochemical and structural information can be obtained without labelling [88].

Raman spectroscopy is an analytical tool for cancer research [89]. Real-time *in vivo* cancer diagnosis using Raman spectroscopy is currently developing [87, 90]. It is now applied to the analysis of biofluids [91]. The combination of Raman spectroscopy, which measures molecular vibrations, and Raman optical activity, which measures the small difference in Raman Scattering from chiral molecules using circularly polarized light, can provide information about the structure and conformational dynamics of biological molecules such as GAGs [80]. In the present review, we analysed for the first time normalized Raman spectra from single live cells of CHO-745, CHO-WT, and chondrocytes. The Raman analysis was performed at 1750–600 cm⁻¹ spectral range. In Fig. 7, HCA analysis showed a low degree of heterogeneity, indicating a good reproducibility of the measurements and, therefore, a low intra-group variability. The inter-group variability was good enough to distinguish the three cell types (Fig. 7). The dendrogram clearly differentiated between chondrocytes and both CHO-WT and CHO-745. PCA (not shown) demonstrated the prominence of the information related to GAGs.

<figure><img src="image_12.png" /><figcaption>**Fig. 7** Hierarchical cluster analysis of live cells Raman spectra. HCA was calculated on the second derivative of the mean spectra of each cell type in the spectral range 600–1750 cm⁻¹. All replicate spectra of the same sample are well clustered together</figcaption></figure>
FTIR and Raman spectroscopies are emerging analyti-
cal techniques that are complementary, straight-forward,
and easy-to-use. They allow molecular characterization
of GAG either as standards or in complex biological sys-
tems such as cells. FTIR can be used either in a high-
throughput approach for analyzing CM and fixed cell
populations or in the imaging mode, where isolated fixed
single cells can be investigated. In this case, the spectral
information obtained is a snapshot of the differentiation or
proliferation state of the cell. Thus, it is possible to ana-
lyze intra- and peri-cellular GAGs at a given time. The
FTIR spectral data allow to screen and to discriminate
cells according to their capacity of GAG synthesis. FTIR
is sensitive to the degree of sulfation of GAGs. IR
microspectroscopy of live cells is feasible but remains
challenging.

Complementary to FTIR, RMS also allows to analyze
CM and cells. However, RMS offers a better spatial res-
olution, which renders measurements in subcellular com-
partments. In addition, water being a weak scatter, inves-
tigation of live cells in physiological conditions is feasi-
ble. Thus, GAGs can be analyzed in a native conforma-
tion unaltered by chemical fixation. In a complementary
way, RMS is more sensitive to glycosidic bonds. In this
study, we have used the 660 nm excitation but other
lasers from the visible to the near-IR can be adapted to
analyze intra- and peri-cellular GAGs.

Conclusions and outlook

As succinctly reviewed here, high-throughput FTIR and
Raman spectroscopies have evolved to a point at which cells
with different capacities of GAG synthesis can be discriminat-
ed. Thus, it is possible, *via* the use of two different chemomet-
ric clustering approaches, to distinguish between the CHO-
WT cell line and its mutant counterpart, CHO-745, lacking
xylosyltransferase associated with low GAG synthesis. The
inter-group differences were more marked when the latter
two cell lines were compared to the primary culture from
human chondrocytes expressing high levels of GAGs.
Therefore, VS could be developed for cell screening purposes
distinguishing cell types exhibiting from low to high levels of
GAG synthesis and further for identifying GAG molecules in
tissues. Taking into account the importance of GAGs in the
biomedical field, it will be challenging and further work is
needed to transpose the methodology to tissue analysis in
order to identify GAG molecules in normal tissues and during
pathophysiological conditions. In a mid-term perspective,
in vivo RMS could be developed to search for GAG spectral
signatures in peritumoral margins of certain tumors as a mark-
er of tumor progression.

**Acknowledgments** Financial support from the European commission, H2020-MSCA-RISE-2014, funding scheme Marie Skłodowska-Curie, Research of Innovation Staff Exchange (RISE), GLYCANC ID 645756, the Ligue Nationale contre le Cancer (Comité de la Marne et Comité de Haute-Marne, Conférence de Coordination InterRégionale du Grand Est (CCIR-GE)), the FEDER and the Région Champagne-Ardenne (CPER 2015–2019), is gratefully acknowledged. The authors thank the Reims PICT-IBiSA Platform.

**Author contributions** Conceived and designed the study: S.B. and G.D.S.

Analysed and interpreted the data: S.B., V.U., H.T.M., and G.D.S.

Wrote the manuscript: H.T.M., V.U., S.B., and G.D.S.

Revised the manuscript for important intellectual content: S.B. and G.D.S.

Supervised the study: S.B. and G.D.S.

All authors approved the manuscript

Compliance with ethical standards

**Conflicts of interest** The authors declare that they have no conflicts of interest.

**Ethical approval** This article does not contain any studies with human participants or animals performed by any of the authors.

**Competing financial interest** These authors declare no competing financial interests.

**Open Access** This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

References

1. Iozzo, R.V.: Matrix proteoglycans: from molecular design to cellular function. Annu. Rev. Biochem. **67**, 609–652 (1998)

2. Afratis, N., Gialeli, C., Nikitovic, D., Tsegenidis, T., Karousou, E., Theocharis, A.D., Pavao, M.S., Tzanakakis, G.N., Karamanos, N.K.: Glycosaminoglycans: key players in cancer cell biology and treatment. FEBS J. **279**(7), 1177–1197 (2012)

3. Esko, J.D., Kimata, K., Lindahl, U.: Proteoglycans and sulfated glycosaminoglycans. In: Varki, A., Cummings, R.D., Esko, J.D., Freeze, H.H., Stanley, P., Bertozzi, C.R., Hart, G.W., Etzler, M.E. (eds.) Essentials of glycobiology. Cold Spring Harbor, NY (2009)

4. Souza-Fernandes, A.B., Pelosi, P., Rocco, P.R.: Bench-to-bedside review: the role of glycosaminoglycans in respiratory disease. Crit. Care **10**(6), 237 (2006)

5. Maccari, F., Mantovani, V., Gabrielli, O., Carlucci, A., Zampini, L., Galeazzi, T., Galeotti, F., Coppa, G.V., Volpi, N.: Metabolic fate of milk glycosaminoglycans in breastfed and formula fed newborns. Glycoconj. J. **33**(2), 181–188 (2016)

6. Yip, G.W., Smollich, M., Gotte, M.: Therapeutic value of glycosaminoglycans in cancer. Mol. Cancer Ther. **5**(9), 2139–2148 (2006)

7. Duchez, S., Pascal, V., Cogne, N., Jayat-Vignoles, C., Julien, R., Cogne, M.: Glycotranscriptome study reveals an enzymatic switch
modulating glycosaminoglycan synthesis during B-cell develop-
ment and activation. Eur. J. Immunol. **41**(12), 3632–3644 (2011)

8. Brézillon, S., Pietraszek, K., Maquart, F.X., Wegrowski, Y.: Lumican effects in the control of tumour progression and their links with metalloproteinases and integrins. *FEBS J.* **280**(10), 2369–2381 (2013)

9. Chakravarti, S., Magnuson, T., Lass, J.H., Jepsen, K.J., LaMantia, C., Carroll, H.: Lumican regulates collagen fibril assembly: skin fragility and corneal opacity in the absence of lumican. J. Cell Biol. **141**(5), 1277–1286 (1998)

10. Liu, C.Y., Kao, W.W.: Lumican promotes corneal epithelial wound healing. Methods Mol. Biol. **836**, 285–290 (2012)

11. Raman, R., Sasisekharan, V., Sasisekharan, R.: Structural insights into biological roles of protein-glycosaminoglycan interactions. Chem. Biol. **12**(3), 267–277 (2005)

12. Mizumoto, S., Ikegawa, S., Sugahara, K.: Human genetic disorders caused by mutations in genes encoding biosynthetic enzymes for sulfated glycosaminoglycans. J. Biol. Chem. **288**(16), 10953–10961 (2013)

13. Pacella, E., Pacella, F., De Paolis, G., Parisella, F.R., Turchetti, P., Anello, G., Cavallotti, C.: Glycosaminoglycans in the human cornea: age-related changes. Ophthalmol Eye Dis **7**, 1–5 (2015)

14. Schwertfeger, K.L., Cowman, M.K., Telmer, P.G., Turley, E.A., McCarthy, J.B.: Hyaluronan, inflammation, and breast cancer progression. Front. Immunol. **6**, 236 (2015)

15. Udabage, L., Brownlee, G.R., Waltham, M., Blick, T., Walker, E.C., Heldin, P., Nilsson, S.K., Thompson, E.W., Brown, T.J.: Antisense-mediated suppression of hyaluronan synthase 2 inhibits the tumorigenesis and progression of breast cancer. Cancer Res. **65**(14), 6139–6150 (2005)

16. Yang, J., Price, M.A., Neudauer, C.L., Wilson, C., Ferrone, S., Xia, H., Iida, J., Simpson, M.A., McCarthy, J.B.: Melanoma chondroitin sulfate proteoglycan enhances FAK and ERK activation by distinct mechanisms. J. Cell Biol. **165**(6), 881–891 (2004)

17. Kim, S.H., Turnbull, J., Guimond, S.: Extracellular matrix and cell signalling: the dynamic cooperation of integrin, proteoglycan and growth factor receptor. J. Endocrinol. **209**(2), 139–151 (2011)

18. Itano, N., Sawai, T., Miyaishi, O., Kimata, K.: Relationship between hyaluronan production and metastatic potential of mouse mammary carcinoma cells. Cancer Res. **59**(10), 2499–2504 (1999)

19. Roy, M., Marchetti, D.: Cell surface heparan sulfate released by heparanase promotes melanoma cell migration and angiogenesis. J. Cell. Biochem. **106**(2), 200–209 (2009)

20. Teng, Y.H., Aquino, R.S., Park, P.W.: Molecular functions of syndecan-1 in disease. Matrix Biol.: J. Int. Soc. Matrix Biol. **31**(1), 3–16 (2012)

21. Jiang, X., Couchman, J.R.: Perlecan and tumor angiogenesis. J. Histochem. Cytochem. : Off. J. Histochem. Soc. **51**(11), 1393–1410 (2003)

22. Neill, T., Painter, H., Buraschi, S., Owens, R.T., Lisanti, M.P., Schaefer, L., Iozzo, R.V.: Decorin antagonizes the angiogenic network: concurrent inhibition of Met, hypoxia inducible factor 1 alpha, vascular endothelial growth factor A, and induction of thrombospondin-1 and TIMP3. J. Biol. Chem. **287**(8), 5492–5506 (2012)

23. Siddiqui, MF., Nandi, P., Girish, GV., Nygard, K., Eastabrook, G., de Vrijer, B., Han, VK., Lala, PK.: Decorin over-expression by decidual cells in preeclampsia: a potential blood biomarker. Am. J. Obstet. Gynecol. S0002-9378(16), 00489-0 (2016)

24. Ida, M., Shuo, T., Hirano, K., Tokita, Y., Nakanishi, K., Matsui, F., Aono, S., Fujita, H., Fujiwara, Y., Kaji, T., Oohira, A.: Identification and functions of chondroitin sulfate in the milieu of neural stem cells. J. Biol. Chem. **281**(9), 5982–5991 (2006)

25. Netelenbos, T., van den Born, J., Kessler, F.L., Zweegman, S., Merle, P.A., van Oostveen, J.W., Zwaginga, J.J., Huijgens, P.C., Drager, A.M.: Proteoglycans on bone marrow endothelial cells bind

and present SDF-1 towards hematopoietic progenitor cells. Leukemia **17**(1), 175–184 (2003)

26. Chen, S.G., Xue, C.H., Yin, L.A., Tang, Q.J., Yu, G.L., Chai, W.G.: Comparison of structures and anticoagulant activities of fucosylated chondroitin sulfates from different sea cucumbers. Carbohydr. Polym. **83**(2), 688–696 (2011)

27. Hileman, R.E., Smith, A.E., Toida, T., Linhardt, R.J.: Preparation and structure of heparin lyase-derived heparan sulfate oligosaccharides. Glycobiology **7**(2), 231–239 (1997)

28. MacNair, J.E., Lewis, K.C., Jorgenson, J.W.: Ultrahigh-pressure reversed-phase liquid chromatography in packed capillary columns. Anal. Chem. **69**(6), 983–989 (1997)

29. Fura, A., Leary, J.A.: Differentiation of Ca(2+)- and Mg(2+)-coordinated branched trisaccharide isomers: an electrospray ionization and tandem mass spectrometry study. Anal. Chem. **65**(20), 2805–2811 (1993)

30. Volpi, N., Maccari, F., Linhardt, R.J.: Quantitative capillary electrophoresis determination of oversulfated chondroitin sulfate as a contaminant in heparin preparations. Anal. Biochem. **388**(1), 140–145 (2009)

31. Lamari, F.N., Militisopoulou, M., Mitropoulou, T.N., Hjerpe, A., Karamanos, N.K.: Analysis of glycosaminoglycan-derived disaccharides in biologic samples by capillary electrophoresis and protocol for sequencing glycosaminoglycans. Biomed. Chromatogr. **16**(2), 95–102 (2002)

32. Plaas, AH., West, L., Midura, RJ., Hascall, VC.: Disaccharide composition of hyaluronan and chondroitin/dermatan sulfate: Analysis with fluorophore-assisted carbohydrate electrophoresis. In: Iozzo, R. V. (ed) Methods in molecular biology; Vol 171 (2001)

33. Liu, Z.L., Masuko, S., Solakyildirim, K., Pu, D., Linhardt, R.J., Zhang, F.M.: Glycosaminoglycans of the Porcine Central Nervous System. Biochemistry. **49**(45), 9839–9847 (2010)

34. Li, B.Y.Z., Liu, H.Y., Zhang, Z.Q., Stansfield, H.E., Dordick, J.S., Linhardt, R.J.: Analysis of glycosaminoglycans in stem cell glycomics. Methods Mol. Biol. **690**, 285–300 (2011)

35. Cecchi, T., Passamonti, P.: Retention mechanism for ion-pair chromatography with chaotropic reagents (vol 1216, pg 1789, 2009). J. Chromatogr. A **1216**(26), 5164–5164 (2009)

36. Cecchi, T., Pucciarelli, F., Passamonti, P.: Extended thermodynamic approach to ion-interaction chromatography for high surface potential: use of potential approximation for simplified retention equations. Chromatographia **54**(9–10), 589–593 (2001)

37. Jones, C.J., Beni, S., Limtiaco, J.F.K., Langeslay, D.J., Larive, C.K.: Heparin characterization: challenges and solutions. Annu. Rev. Anal. Chem. **4**, 439–465 (2011)

38. Cecchi, T., Pucciarelli, F., Passamonti, P.: Extended thermodynamic approach to ion interaction chromatography. Anal. Chem. **73**(11), 2632–2639 (2001)

39. Reinhold, V.N., Reinhold, B.B., Costello, C.E.: Carbohydrate molecular weight profiling, sequence, linkage, and branching data: ES-MS and CID. Anal. Chem. **67**(11), 1772–1784 (1995)

40. Juhasz, P., Biemann, K.: Mass spectrometric molecular-weight determination of highly acidic compounds of biological significance via their complexes with basic polypeptides. Proc. Natl. Acad. Sci. U. S. A. **91**(10), 4333–4337 (1994)

41. Shriver, Z., Raman, R., Venkataraman, G., Drummond, K., Turnbull, J., Toida, T., Linhardt, R., Biemann, K., Sasisekharan, R.: Sequencing of 3-O sulfate containing heparin decasaccharides with a partial antithrombin III binding site. Proc. Natl. Acad. Sci. U. S. A. **97**(19), 10359–10364 (2000)

42. Takagaki, K., Munakata, H., Nakamura, W., Matsuya, H., Majima, M., Endo, M.: Ion-spray mass spectrometry for identification of the nonreducing terminal sugar of glycosaminoglycan. Glycobiology **8**(7), 719–724 (1998)

43. Pervin, A., Gallo, C., Jandik, K.A., Han, X.J., Linhardt, R.J.: Preparation and structural characterization of large heparin-derived oligosaccharides. Glycobiology **5**(1), 83–95 (1995)
44. Yang, H.O., Gunay, N.S., Toida, T., Kuberan, B., Yu, G., Kim, Y.S., Linhardt, R.J.: Preparation and structural determination of dermatan sulfate-derived oligosaccharides. *Glycobiology* **10**(10), 1033–1039 (2000)

45. Mao, W.J., Thanawiroon, C., Linhardt, R.J.: Capillary electrophoresis for the analysis of glycosaminoglycans and glycosaminoglycan-derived oligosaccharides. *Biomed. Chromatogr.* **16**(2), 77–94 (2002)

46. Ruiz-Calero, V., Moyano, E., Puignou, L., Galceran, M.T.: Pressure-assisted capillary electrophoresis-electrospray ion trap mass spectrometry for the analysis of heparin depolymerised disaccharides. *J. Chromatogr. A* **914**(1–2), 277–291 (2001)

47. Zamfir, A., Seidler, D.G., Kresse, H., Peter-Katalinic, J.: Structural characterization of chondroitin/dermatan sulfate oligosaccharides from bovine aorta by capillary electrophoresis and electrospray ionization quadrupole time-of-flight tandem mass spectrometry. *Rapid Commun. Mass Spectrom.* **16**(21), 2015–2024 (2002)

48. Behnke, B., Schlotterbeck, G., Tallarek, U., Strohschein, S., Tseng, L.H., Keller, T., Albert, K., Bayer, E.: Capillary HPLC-NMR coupling high-resolution NMR spectroscopy in the nanoliter scale. *Anal. Chem.* **68**(7), 1110–1115 (1996)

49. Chang, Y.Q., Yang, B., Zhao, X., Linhardt, R.J.: Analysis of glycosaminoglycan-derived disaccharides by capillary electrophoresis using laser-induced fluorescence detection. *Anal. Biochem.* **427**(1), 91–98 (2012)

50. Karousou, E., Asimakopoulou, A.P., Zafeiropoulou, V., Viola, M., Monti, L., Rossi, A., Passi, A., Karamanos, N.: Fast screening of glycosaminoglycan disaccharides by fluorophore-assisted carbohydrate electrophoresis (FACE): applications to biologic samples and pharmaceutical formulations. *Methods Mol. Biol.* **1229**, 143–159 (2015)

51. Karousou, E., Asimakopoulou, A., Monti, L., Zafeiropoulou, V., Afratis, N., Gartaganis, P., Rossi, A., Passi, A., Karamanos, N.K.: FACE analysis as a fast and reliable methodology to monitor the sulfation and total amount of chondroitin sulfate in biological samples of clinical importance. *Molecules* **19**(6), 7959–7980 (2014)

52. Mainreck, N., Brézillon, S., Sockalingum, G.D., Maquart, F.X., Manfait, M., Wegrowski, Y.: Rapid characterization of glycosaminoglycans using a combined approach by infrared and Raman microspectroscopies. *J. Pharm. Sci.* **100**(2), 441–450 (2011)

53. Mainreck, N., Brézillon, S., Sockalingum, G.D., Maquart, F.X., Manfait, M., Wegrowski, Y.: Characterization of glycosaminoglycans by tandem vibrational microspectroscopy and multivariate data analysis. *Methods Mol. Biol.* **836**, 117–130 (2012)

54. Brézillon, S., Untereiner, V., Lovergne, L., Tadeo, I., Noguera, R., Maquart, F.X., Wegrowski, Y., Sockalingum, G.D.: Glycosaminoglycan profiling in different cell types using infrared spectroscopy and imaging. *Anal. Bioanal. Chem.* **406**(24), 5795–5803 (2014)

55. Parker, F.S.: Applications of infrared, Raman, and resonance Raman spectroscopy in biochemistry. Springer, Heidelberg (1983)

56. Orr, S.F.: Intra-red spectroscopic studies of some polysaccharides. *Biochim. Biophys. Acta* **14**(2), 173–181 (1954)

57. Gilli, R., Kacuráková, M., Mathlouthi, M., Navarini, L., Paoletti, S.: FTIR studies of sodium hyaluronate and its oligomers in the amorphous solid phase and in aqueous solution. *Carbohydr. Res.* **263**, 315–326 (1994)

58. Lee, S., Myers, L., Powell, J., Suleski, T., Rupprecht, A.: Raman and infrared studies of wet spun films of Na-hyaluronate. *J. Biomol. Struct. Dyn.* **11**(1), 191–201 (1993)

59. Servaty, R., Schiller, J., Binder, H., Arnold, K.: Hydration of polymeric components of cartilage–an infrared spectroscopic study on hyaluronic acid and chondroitin sulfate. *Int. J. Biol. Macromol.* **28**, 121–127 (2001)

60. Maréchal, Y., Milas, M., Rinaudo, M.: Hydration of hyaluronan polysaccharide observed by IR spectrometry. III. Structure and mechanism of hydration. *Biopolymers* **72**(3), 162–173 (2003)

61. Haxaire, K., Maréchal, Y., Milas, M., Rinaudo, M.: Hydration of polysaccharide hyaluronan observed by IR spectrometry. I. Preliminary experiments and peak assignments. *Biopolymers* **72**, 10–20 (2003)

62. Haxaire, K., Maréchal, Y., Milas, M., Rinaudo, M.: Hydration of hyaluronan polysaccharide observed by IR spectrometry. II. Definition and quantitative analysis of elementary hydration spectra and water uptake. *Biopolymers* **72**(3), 149–161 (2003)

63. Reineck, I., DeAnna, J., Suleski, T., Lee, S., Rupprecht, A.: A Raman study of the hydration of wet-spun films of Li-hyaluronate. *J. Biomol. Struct. Dyn.* **21**(1), 153–157 (2003)

64. Garnjanagoonchorn, W., Wongekalak, L., Engkagul, A.: Determination of chondroitin sulfate from different sources of cartilage. *Chem. Eng. Process. Process Intensif.* **46**, 465–471 (2007)

65. Bychkov, S., Bogatov, V., Kuz'mina, S.: Comparative study of the IR-spectra of glycosaminoglycans and their monomers. *Biull. Eksp. Biol. Med.* **91**, 442–445 (1981)

66. Bansil, R., Yannas, I., Stanley, H.: Raman spectroscopy: a structural probe of glycosaminoglycans. *Biochim. Biophys. Acta* **541**(4), 535–542 (1978)

67. Terho, T., Hartiala, K., Hakkinen, I.: Infrared spectroscopic investigations of a new acid mucopolysaccharide isolated from human gastric juice. *Nature* **211**(5045), 198–199 (1996)

68. Cabassi, F., Casu, B., Perlin, A.S.: Infrared absorption and Raman scattering of sulfate groups of heparin and related glycosaminoglycans in aqueous solution. *Carbohydr. Res.* **63**(C), 1–11 (1978)

69. Longas, M., Breitweiser, K.: Sulfate composition of glycosaminoglycans determined by infrared spectroscopy. *Anal. Biochem.* **192**(1), 193–196 (1991)

70. Atha, D., Gaigalas, A., Reipa, V.: Structural analysis of heparin by Raman spectroscopy. *J. Pharm. Sci.* **85**(1), 52–56 (1996)

71. Grant, D., Long, W., Moffat, C., Williamson, F.: Infrared spectroscopy as a method for investigating the conformations of iduronate saccharide residues in glycosaminoglycans. *Biochem. Soc. Trans.* **18**(6), 1277–1279 (1990)

72. Grant, D., Long, W., Moffat, C., Williamson, F.: Effect of chemical reduction of the iduronate of heparin on IR absorption peaks sensitive to sugar conformation. *Biochem. Soc. Trans.* **18**(6), 1279–1280 (1990)

73. Grant, D., Long, W., Williamson, F.: A possible ring conformational change of iduronate residues detected by i.r. spectroscopy of aqueous solutions of lithium-heparin. *Biochem. Soc. Trans.* **18**(6), 1281–1282 (1990)

74. Grant, D., Long, W., Moffat, C., Williamson, F.: Infrared spectroscopy of heparins suggests that the region 750–950 cm⁻¹ is, sensitive to changes in iduronate residue ring conformation. *Biochem. J.* **275**(Pt 1), 193–197 (1991)

75. Ellis, R., Green, E., Winlove, C.: Structural analysis of glycosaminoglycans and proteoglycans by means of Raman microspectrometry. *Connect. Tissue Res.* **50**(1), 29–36 (2009)

76. Longas, M., Russell, C., He, X.: Chemical alterations of hyaluronic acid and dermatan sulfate detected in aging human skin by infrared spectroscopy. *Biochim. Biophys. Acta* **884**(2), 265–269 (1986)

77. Longas, M., Russell, C., He, X.: Evidence for structural changes in dermatan sulfate and hyaluronic acid with aging. *Carbohydr. Res.* **159**(1), 127–136 (1987)

78. Foot, M., Mulholland, M.: Classification of chondroitin sulfate A, chondroitin sulfate C, glucosamine hydrochloride and glucosamine 6 sulfate using chemometric techniques. *J. Pharm. Biomed. Anal.* **38**(3), 397–407 (2005)

79. Movasaghi, Z., Rehman, S., Rehman, I.: Raman spectroscopy of biological tissues. *Appl. Spectrosc. Rev.* **42**, 493–541 (2007)

80. Miller, G.J., Hansen, S.U., Baráth, M., Johannessen, C., Blanch, E.W., Jayson, G.C., Gardiner, J.M.: Synthesis of a heparin-related GlycN-
IdoA sulfation-site variable disaccharide library and analysis by Raman and ROA spectroscopy. Carbohydr. Res. **400**, 44–53 (2014)

81. Kamilari, E., Kontoyannis, C., Lamari, F., Orkoula, M.: Investigation of GAG-collagen interactions using spectroscopic techniques. 9th Panhellenic Scientific Chemical Engineering Congress, May 23-25th 2013

82. Draux, F., Jeannesson, P., Beljebbar, A., Tfayli, A., Fourre, N., Manfait, M., Sulé-Suso, J., Sockalingum, G.D.: Raman spectral imaging of single living cancer cells: a preliminary study. *Analyst* **134**(3), 542–548 (2009)

83. Draux, F., Gobinet, C., Sulé-Suso, J., Trussardi, A., Manfait, M., Jeannesson, P., Sockalingum, G.D.: Raman spectral imaging of single cancer cells: probing the impact of sample fixation methods. *Anal. Bioanal. Chem.* **397**(7), 2727–2737 (2010)

84. Draux, F., Gobinet, C., Sulé-Suso, J., Manfait, M., Jeannesson, P., Sockalingum, G.D.: Raman imaging of single living cells: probing effects of non-cytotoxic doses of an anti-cancer drug. *Analyst* **136**(13), 2718–2725 (2011)

85. Tfayli, A., Piot, O., Draux, F., Pitre, F., Manfait, M.: Molecular characterization of reconstructed skin model by Raman microspectroscopy: comparison with excised human skin. *Biopolymers* **87**(4), 261–274 (2007)

86. Craig, D., McAugthrie, S., Simpson, J., McCraw, C., Faulds, K., Graham, D.: Confocal SERS mapping of glycan expression for the

identification of cancerous cells. Anal. Chem. **86**(10), 4775–4782 (2013)

87. Wang, W., Zhao, J., Short, M., Zeng, H.: Real-time *in vivo* cancer diagnosis using Raman spectroscopy. J. Biophotonics **8**(7), 527–545 (2015)

88. Butler, H.J., Ashton, L., Bird, B., Cinque, G., Curtis, K., Dorney, J., Esmonde-White, K., Fullwood, N.J., Gardner, B., Martin-Hirsch, P.L., Walsh, M.J., McAinsh, M.R., Stone, N., Martin, F.L.: Using Raman spectroscopy to characterize biological materials. Nat. Protoc. **11**(4), 664–687 (2016)

89. Brauchle, E., Noor, S., Holtorf, E., Garbe, C., Schenke-Layland, K., Busch, C.: Raman spectroscopy as an analytical tool for melanoma research. Clin. Exp. Dermatol. **39**(5), 636–645 (2014)

90. Bergholt, M.S., Lin, K., Wang, J., Zheng, W., Xu, H., Huang, Q., Ren, J.L., Ho, K.Y., The, M., Srivastava, S., Wong, B., Yeoh, K.G., Huang, Z.: Simultaneous fingerprint and high-wavenumber fiber-optic Raman spectroscopy enhances real-time *in vivo* diagnosis of adenomatous polyps during colonoscopy. J. Biophotonics **9**(4), 333–342 (2016)

91. Baker, M.J., Hussain, S.R., Lovergne, L., Untereiner, V., Hughes, C., Lukaszewski, R.A., Thiéfin, G., Sockalingum, G.D.: Developing and understanding biofluid vibrational spectroscopy: a critical review. Chem. Soc. Rev. **45**(7), 1803–1818 (2016)